JP2024500945A5 - - Google Patents
Info
- Publication number
- JP2024500945A5 JP2024500945A5 JP2023538766A JP2023538766A JP2024500945A5 JP 2024500945 A5 JP2024500945 A5 JP 2024500945A5 JP 2023538766 A JP2023538766 A JP 2023538766A JP 2023538766 A JP2023538766 A JP 2023538766A JP 2024500945 A5 JP2024500945 A5 JP 2024500945A5
- Authority
- JP
- Japan
- Prior art keywords
- immunotherapy
- protein
- fcγriib
- lower hinge
- protein according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020904823 | 2020-10-22 | ||
| AU2020904823A AU2020904823A0 (en) | 2020-12-23 | Modified immunoglobulin and method of use thereof (1) | |
| PCT/AU2021/051548 WO2022133543A1 (en) | 2020-12-23 | 2021-12-22 | Modified immunoglobulin with affinity for fcgammariib and method of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024500945A JP2024500945A (ja) | 2024-01-10 |
| JP2024500945A5 true JP2024500945A5 (https=) | 2025-01-06 |
Family
ID=82156888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023538766A Pending JP2024500945A (ja) | 2020-12-23 | 2021-12-22 | ＦｃガンマＲＩＩｂに対する親和性を有する修飾免疫グロブリン及びその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240018269A1 (https=) |
| EP (1) | EP4267627A4 (https=) |
| JP (1) | JP2024500945A (https=) |
| AU (1) | AU2021408091A1 (https=) |
| WO (1) | WO2022133543A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250122541A (ko) | 2022-10-25 | 2025-08-13 | 사이즈믹 테라퓨틱, 인코포레이티드. | 변이체 IgG FC 폴리펩티드 및 그 용도 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180360981A1 (en) * | 2003-09-26 | 2018-12-20 | Xencor, Inc. | Novel immunoglobulin variants |
| EP2176298B1 (en) * | 2007-05-30 | 2017-11-15 | Xencor, Inc. | Methods and compositions for inhibiting cd32b expressing cells |
| WO2017214452A1 (en) * | 2016-06-08 | 2017-12-14 | Xencor, Inc. | Treatment of igg4-related diseases with anti-cd19 antibodies crossbinding to cd32b |
| CN113603780B (zh) * | 2017-03-28 | 2022-07-01 | 礼进生物医药科技（上海）有限公司 | 用于增强肿瘤微环境中免疫应答的治疗剂和方法 |
| JP7626698B2 (ja) * | 2018-09-28 | 2025-02-04 | リビジェン バイオファーマ ホールディングス リミテッド | 操作されたＦｃドメインを有する抗ＣＤ４０結合分子およびその治療用途 |
| WO2020069382A1 (en) * | 2018-09-28 | 2020-04-02 | Lyvgen Biopharma Co., Ltd. | Anti-cd137 binding molecules having engineered fc domains and therapeutic uses thereof |
| CN116368154A (zh) * | 2020-10-08 | 2023-06-30 | 阿菲姆德股份有限公司 | 三特异性结合剂 |
-
2021
- 2021-12-22 JP JP2023538766A patent/JP2024500945A/ja active Pending
- 2021-12-22 EP EP21908155.1A patent/EP4267627A4/en not_active Withdrawn
- 2021-12-22 WO PCT/AU2021/051548 patent/WO2022133543A1/en not_active Ceased
- 2021-12-22 AU AU2021408091A patent/AU2021408091A1/en not_active Abandoned
-
2023
- 2023-06-23 US US18/213,344 patent/US20240018269A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7589269B2 (ja) | 抗ｂｃｍａ重鎖のみ抗体 | |
| JP6835591B2 (ja) | Ｉｇｆ−１ｒ抗体および癌処置のためのアドレッシングビヒクルとしてのその使用 | |
| JP7257971B2 (ja) | 抗ｃｄ４０抗体、その抗原結合フラグメント、およびその医学的使用 | |
| JP2024112978A (ja) | アゴニスト抗体の活性を増強する抗体重鎖定常領域配列 | |
| JP2021503455A5 (https=) | ||
| TW201833141A (zh) | 抗b7-h3抗體、其抗原結合片段及其醫藥用途 | |
| JP2021508449A5 (https=) | ||
| JP2018510617A5 (https=) | ||
| JP2022509156A (ja) | 抗ｃｄ４０抗体、その抗原結合フラグメント、およびその医学的使用 | |
| WO2023186120A1 (zh) | 抗血清白蛋白纳米抗体及其衍生物 | |
| JP6808611B2 (ja) | Ｆｃγ受容体ＩＩＢおよびＦｃε受容体に対する新規の抗体 | |
| KR102058381B1 (ko) | 인간 ｌ１ｃａｍ에 대한 인간화 항체 및 그의 제조 방법 | |
| JP2018512124A (ja) | トランスフォーミング増殖因子β１に高親和性、アビディティおよび特異性で結合する修飾ＩｇＧ抗体 | |
| JP2021511387A5 (https=) | ||
| JP2024501771A5 (https=) | ||
| JP2025541367A (ja) | 多価および多重特異性サイトカインアンタゴニスト | |
| CN108948193B (zh) | 针对tim-3的抗体分子,抗原结合片段及其医药用途 | |
| JP2024500945A5 (https=) | ||
| JP2023531230A5 (https=) | ||
| JP2019514343A5 (https=) | ||
| KR20230117178A (ko) | T 세포 인게이저 치료제의 개발 및 적용 | |
| JP2025026957A (ja) | ＩＬ－１β受容体シグナル伝達に干渉する剤 | |
| WO2024061224A1 (zh) | 抗her2抗体及其用途 | |
| JP2024544757A5 (https=) | ||
| CN118909109B (zh) | 靶向vsig4的抗体或其抗原结合片段及其用途 |